Paper28538732
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells.
Kim J and 25 others. Nature, 2017. Cited by 289 papers, by iCite.
Cite this record
ConductScience Library. CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. Papers, record 28538732. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28538732
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics30
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbamoyl-Phosphate Synthase (Ammonia) | Major topic |
| DNA | Major topic |
| Lung Neoplasms | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Proto-Oncogene Proteins p21(ras) | Major topic |
| Pyrimidines | Major topic |
| AMP-Activated Protein Kinase Kinases | |
| AMP-Activated Protein Kinases | |
| Ammonia | |
| Animals | |
| Bicarbonates | |
| Carbamyl Phosphate | |
| Carcinoma, Non-Small-Cell Lung | |
| Cell Death | |
| Cell Proliferation | |
| DNA Damage | |
| DNA Replication | |
| DNA-Directed DNA Polymerase | |
| Female | |
| Gene Silencing | |
| Humans | |
| Male | |
| Metabolomics | |
| Mice | |
| Mitochondria | |
| Nitrogen | |
| Purines | |
| S Phase | |
| Transcription, Genetic | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA157996 | NCI NIH HHS | United States | R01CA157996 | PubMed and NIH | NIH RePORTER |
| R01 CA196912 | NCI NIH HHS | United States | R01CA196912 | PubMed and NIH | NIH RePORTER |
| R01 DK111430 | NIDDK NIH HHS | United States | R01DK111430 | PubMed and NIH | NIH RePORTER |
| P50 CA070907 | NCI NIH HHS | United States | P50CA070907 | PubMed and NIH | NIH RePORTER |
| U01 CA176284 | NCI NIH HHS | United States | U01CA176284 | PubMed and NIH | NIH RePORTER |
| K01 DK093543 | NIDDK NIH HHS | United States | K01DK093543 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 31043737 | Author Correction: CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells. | https://conductscience.org/library/papers/31043737 |
Source PubMed
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28376202 | Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma. | J Natl Cancer Inst | 2017 | https://conductscience.org/library/papers/28376202 | PubMed |
| 2 | 2565865 | Mapping of the gene encoding the multifunctional protein carrying out the first three steps of pyrimidine biosynthesis to human chromosome 2. | Hum Genet | 1989 | https://conductscience.org/library/papers/2565865 | PubMed |
| 3 | 24857658 | Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. | Cell Rep | 2014 | https://conductscience.org/library/papers/24857658 | PubMed |
| 4 | 20188668 | Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. | Mol Cell | 2010 | https://conductscience.org/library/papers/20188668 | PubMed |
| 5 | 27274280 | Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway. | Onco Targets Ther | 2016 | https://conductscience.org/library/papers/27274280 | PubMed |
| 6 | 9508763 | Replicon clusters are stable units of chromosome structure: evidence that nuclear organization contributes to the efficient activation and propagation of S phase in human cells. | J Cell Biol | 1998 | https://conductscience.org/library/papers/9508763 | PubMed |
| 7 | 1967494 | Mammalian dihydroorotase: nucleotide sequence, peptide sequences, and evolution of the dihydroorotase domain of the multifunctional protein CAD. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/1967494 | PubMed |
| 8 | 22436748 | AMPK: a nutrient and energy sensor that maintains energy homeostasis. | Nat Rev Mol Cell Biol | 2012 | https://conductscience.org/library/papers/22436748 | PubMed |
| 9 | 26766440 | Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription during Hematopoiesis. | Dev Cell | 2016 | https://conductscience.org/library/papers/26766440 | PubMed |
| 10 | 24243015 | Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer. | Cell | 2013 | https://conductscience.org/library/papers/24243015 | PubMed |
| 11 | 23715154 | Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. | Cancer Discov | 2013 | https://conductscience.org/library/papers/23715154 | PubMed |
| 12 | 12914702 | Dynamics of DNA replication in mammalian somatic cells: nucleotide pool modulates origin choice and interorigin spacing. | Cell | 2003 | https://conductscience.org/library/papers/12914702 | PubMed |
| 13 | 22234185 | dNTP pools determine fork progression and origin usage under replication stress. | EMBO J | 2012 | https://conductscience.org/library/papers/22234185 | PubMed |
| 14 | 17676035 | LKB1 modulates lung cancer differentiation and metastasis. | Nature | 2007 | https://conductscience.org/library/papers/17676035 | PubMed |
| 15 | 17401409 | Replication fork barriers: pausing for a break or stalling for time? | EMBO Rep | 2007 | https://conductscience.org/library/papers/17401409 | PubMed |
| 16 | 23535601 | Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. | Nature | 2013 | https://conductscience.org/library/papers/23535601 | PubMed |
| 17 | 25751140 | Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/25751140 | PubMed |
| 18 | 25737507 | Immunohistochemical Loss of LKB1 Is a Biomarker for More Aggressive Biology in KRAS-Mutant Lung Adenocarcinoma. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/25737507 | PubMed |
| 19 | 19629071 | The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19629071 | PubMed |
| 20 | 24336571 | Genome-scale CRISPR-Cas9 knockout screening in human cells. | Science | 2014 | https://conductscience.org/library/papers/24336571 | PubMed |
Cited by230
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 289 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42957627 | Multi-omic profiling reveals metabolic vulnerabilities in enzalutamide resistant prostate cancer. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42957627 | PubMed |
| 42911237 | Lung cancer metabolism: a dynamic and adaptive network. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/42911237 | PubMed |
| 42865665 | LKB1 promotes lung adenocarcinoma cell senescence by suppressing the O-GlcNAc glycosylation-mediated activation of telomerase. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42865665 | PubMed |
| 42840631 | Tumor organoids for testing metabolic flexibility in precision oncology. | Front Oncol | 2026 | https://conductscience.org/library/papers/42840631 | PubMed |
| 42780293 | Microenvironment-derived acetylated amino acids promote glioblastoma treatment resistance. | Res Sq | 2026 | https://conductscience.org/library/papers/42780293 | PubMed |
| 42777710 | A blood-based metabolic signature for earlier detection of lung cancer. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42777710 | PubMed |
| 42738366 | STK11/LKB1 Loss in Cancer: From Developmental Constraint to Stress-Adapted Malignancy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42738366 | PubMed |
| 42733562 | Targeting LKB1-inactivated lung cancers with a stapled peptide inhibitor of the CRTC-CREB pathway. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/42733562 | PubMed |
| 42706347 | ASS1-derived argininosuccinate promotes purine nucleoside synthesis in B cell acute lymphoblastic leukaemia. | Nat Metab | 2026 | https://conductscience.org/library/papers/42706347 | PubMed |
| 42535759 | Stable Isotope-Resolved Metabolomics in Elucidating Mitochondrial Metabolic Reprogramming and Therapeutic Targets. | Biomed Chromatogr | 2026 | https://conductscience.org/library/papers/42535759 | PubMed |
| 42454984 | The Role of Urea Cycle Functional Studies in Preclinical Research. | J Inherit Metab Dis | 2026 | https://conductscience.org/library/papers/42454984 | PubMed |
| 42440946 | Ammonia metabolic reprogramming in the tumor microenvironment: emergence of an immunosuppressive niche. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42440946 | PubMed |
| 42420471 | Dynamic control of nucleotide metabolism in physiology and disease. | Nat Cell Biol | 2026 | https://conductscience.org/library/papers/42420471 | PubMed |
| 42285213 | Molecular insights and therapeutic implications for the tumor suppressor role of LKB1 in non-small cell lung cancer. | Cancer Lett | 2026 | https://conductscience.org/library/papers/42285213 | PubMed |
| 42218515 | ABCC2 as a novel therapeutic target in lung adenocarcinoma: a machine learning-driven discovery linking ammonia metabolism to prognosis and drug resistance. | J Transl Med | 2026 | https://conductscience.org/library/papers/42218515 | PubMed |
| 42163891 | From locus to gene: causal inference and experimental validation prioritize PSMA4 as a candidate target in lung adenocarcinoma. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42163891 | PubMed |
| 42104168 | Leveraging mitochondrial dynamics-related risk signatures to predict the prognosis and tumor microenvironment of lung adenocarcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42104168 | PubMed |
| 42103495 | Bioengineered systems to exploit tumor microenvironment metabolism. | Trends Cancer | 2026 | https://conductscience.org/library/papers/42103495 | PubMed |
| 42074106 | Nitrogen Isotope Effects in Urea Metabolism: From Biochemistry to 15N Natural Abundance in Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074106 | PubMed |
| 42056505 | Nitrogen metabolism profiling reveals cell state-specific pyrimidine synthesis pathway choice. | Nat Metab | 2026 | https://conductscience.org/library/papers/42056505 | PubMed |
Genes26
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28538732
GET https://conductscience.org/api/papers/v1/28538732/authors?page=2